Literature DB >> 14638650

Kava: a test case for Canada's new approach to natural health products.

Heather S Boon1, Albert H C Wong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14638650      PMCID： PMC264955     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Herbal kava: reports of liver toxicity.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2002-03-19       Impact factor: 8.262

2.  Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.

Authors:  M H Pittler; E Ernst
Journal:  J Clin Psychopharmacol       Date:  2000-02       Impact factor: 3.153

3.  Sale of kava extract in some health food stores.

Authors:  Edward Mills; Rana Singh; Cory Ross; Edzard Ernst; Joel G Ray
Journal:  CMAJ       Date:  2003-11-25       Impact factor: 8.262

Review 4.  Therapeutic potential of kava in the treatment of anxiety disorders.

Authors:  Yadhu N Singh; Nirbhay N Singh
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

5.  A systematic review of the safety of kava extract in the treatment of anxiety.

Authors:  Clare Stevinson; Alyson Huntley; Edzard Ernst
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 6.  Kava extracts: safety and risks including rare hepatotoxicity.

Authors:  R Teschke; W Gaus; D Loew
Journal:  Phytomedicine       Date:  2003       Impact factor: 5.340

7.  Kava monograph: a clinical decision support tool.

Authors:  Ethan Basch; Catherine Ulbricht; Paul Hammerness; Candy Tsouronis; David Sollars; Adrianne Rogers; Samuel Basch; Steve Bent; Heather Boon; Edzard Ernst
Journal:  J Herb Pharmacother       Date:  2002
  7 in total
  3 in total

1.  Hepatoxicity associated with weight-loss supplements: a case for better post-marketing surveillance.

Authors:  Ano Lobb
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

2.  Liver toxicity and carcinogenicity in F344/N rats and B6C3F1 mice exposed to Kava Kava.

Authors:  Mamta Behl; Abraham Nyska; Rajendra S Chhabra; Gregory S Travlos; Laurene M Fomby; Barney R Sparrow; Milton R Hejtmancik; Po C Chan
Journal:  Food Chem Toxicol       Date:  2011-08-18       Impact factor: 6.023

Review 3.  Complementary and Alternative Medicines and Patients With Breast Cancer: A Case of Mortality and Systematic Review of Patterns of Use in Patients With Breast Cancer.

Authors:  Grayson A Roumeliotis; Genevieve Dostaler; Kirsty U Boyd
Journal:  Plast Surg (Oakv)       Date:  2017-08-22       Impact factor: 0.947
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.